Caption:MIT researchers demonstrated that their RNA sensor could accurately identify cells expressing a mutated version of the p53 gene, which drives cancer development. [Image courtesy of MIT/iStock]
Engineers at MIT designed a new way to trigger cells that could lead to targeted therapies for cancer and other diseases.Using an RNA sensor for the trigger, the researchers ensure that synthetic genes activate only in specific cells. They demonstrated that the sensor could accurately identify cells expressing a mutated version of the p53 gene, which drives cancer development. Additionally, they found they could turn on a gene encoding a fluorescent protein only within those cells.
With this approach, the engineers feel they can develop sensors to trigger production of cell-killing proteins in cancer cells, sparing healthy cells, too. They see the possibility of developing treatments for other diseases, too…